Hara Episkopou

Dr. Episkopou joined Novadip in 2020. She has 14 years of experience in cancer research dedicated to the identification of new therapeutic targets for the treatment of cancers and in the discovery of new biomarkers for personalized medicine. Most recently, Dr. Episkopou has focused on the development and the extensive characterization of cell therapy products for both academic and private sector. Dr. Episkopou conducted her postdoctoral research at de Duve Institute of UCLouvain, Brussels, Belgium and received her PhD in biomedical science from the Medical School, University of Athens, Greece.